GI Health
|
August 23, 2024

Chronic Clostridioides Difficile (C. diff): Understanding Symptoms, Treatment, and Long-Term Effects

Medically Reviewed by
Updated On
November 8, 2024

Clostridioides difficile (C. diff) is a serious infection that often occurs in hospitals, especially in patients taking antibiotics. It can cause severe stomach problems and is a major concern in healthcare.  Its incidence has doubled in the past two decades to approximately 95 cases per 100,000 in acute care settings.

Chronic C. diff is when the infection keeps coming back and is especially important to address because it can make life very difficult for patients. This article will explain what C. diff is, how it affects people, how it is diagnosed and treated, ways to prevent it from returning, and tips for managing the infection.  

What is C. diff?

Clostridioides difficile, commonly known as C. diff, is a bacteria that can cause severe inflammation of the colon, known as colitis. It is an anaerobic, spore-forming bacterium that naturally resides in the gut of some healthy people without causing harm. 

However, when the normal balance of bacteria in the gut is disrupted, C. diff can overgrow and produce toxins that cause damage to the intestinal lining, leading to symptoms like diarrhea, fever, and abdominal pain.

C. diff infections are classified into two categories: acute and chronic.

  • Acute C. diff infections typically present with sudden, severe symptoms and require prompt medical intervention. 
  • Chronic C. diff infections are marked by recurring episodes of the disease, often challenging to manage and leading to long-term health complications.

How Do You Get C. diff?

C. diff is primarily spread through the fecal-oral route. This means the bacteria or its spores can be transmitted when someone ingests contaminated food, water, or surfaces. 

The image is a diagram that outlines the risk factors associated with getting C. diff, including recent antibiotic use, prolonged hospitalization, a weakened immune system, and advanced age (65 or older).

Risk factors for acquiring C. diff include: 

  • Recent antibiotic use
  • Prolonged hospitalization
  • A weakened immune system (e.g., persons with HIV/AIDS, taking immunosuppressants)
  • Advanced age (65 or older)

The antibiotics most often linked to the risk of C.diff infection include:

  • Cephalosporins
  • Clindamycin
  • Fluoroquinolones
  • Penicillin

C. diff infections can be hospital-acquired or community-acquired:

  • Hospital-acquired infections are more common and typically occur when patients are exposed to the bacteria within healthcare settings, where C. diff spores can persist on surfaces for long periods. 
  • Community-acquired infections, although less common, occur outside of healthcare environments.

Is C. diff Contagious?

C. diff is contagious, particularly in healthcare settings where spores can easily spread from person to person or by contaminated surfaces. 

To prevent the spread of C. diff, take the following precautions: 

  • Practice proper hand hygiene.
  • Use personal protective equipment (PPE).
  • Thoroughly disinfect surfaces with appropriate cleaning agents that kill C. diff spores.

Healthcare providers should isolate infected patients to prevent the bacteria from spreading to others.

What are the Symptoms of C. diff Infection?

C. diff infections range from mild to severe, with symptoms varying in intensity. Common symptoms include:

  • Persistent diarrhea, which may occur multiple times a day, is often accompanied by abdominal pain and cramping.
  • Fever is also a frequent symptom, indicating the body's response to the infection. 
  • Dehydration, nausea, loss of appetite, and weight loss in severe cases.

One of the distinctive signs of C. diff infection is the appearance and odor of the stool. C. diff stool is typically watery, sometimes with a greenish hue, and may contain mucus. It has a distinctive, foul odor, often described as being particularly strong and unpleasant, which can be a key indicator of the infection.

Chronic symptoms may include recurring bouts of diarrhea and abdominal pain, even after initial treatment. This can result in more severe complications, such as inflammation of the colon (colitis) and, in extreme cases, life-threatening conditions like toxic megacolon or sepsis.

How Do You Diagnose a C. diff Infection?

Diagnosing C. diff usually involves a combination of stool tests and other diagnostic methods. 

  • The most common diagnostic approach is a stool test, which looks for C. diff toxins or the bacteria's DNA. These tests are highly specific and sensitive, helping to confirm the diagnosis.
  • In some cases, a colonoscopy or sigmoidoscopy may be performed to visually examine the colon for signs of inflammation or pseudomembranous colitis, a hallmark of severe C. diff infection. 
  • Imaging tests like CT scans might be used in severe cases to assess complications such as colonic distension (the colon wall distends).

Interpretation of test results guides treatment decisions. A positive stool test typically confirms the infection, prompting immediate treatment with antibiotics like vancomycin or fidaxomicin. 

Chronic C. diff and Long-term Implications

Once a person has C. diff, the infection can be challenging to eliminate, leading to high recurrence rates. Approximately 20-30% of individuals experience a recurrence after their initial infection, and some may become chronic carriers, harboring the bacteria without symptoms. This makes them vulnerable to future infections, especially if their gut microbiome becomes disrupted again.

Long-term problems after C. diff include ongoing GI issues such as persistent diarrhea, abdominal pain, and bloating. The risk of recurrence remains high, particularly in those with weakened immune systems or those who continue to take antibiotics. 

These recurring infections can significantly impact a person's quality of life, leading to frequent medical visits, potential hospitalizations, and chronic discomfort.

C. diff Treatment and Management

Antibiotics are the primary treatment for C. diff infections. First-line treatments typically include vancomycin or fidaxomicin for at least 10 days. Metronidazole may be used in mild cases but is less preferred due to its lower efficacy than vancomycin and fidaxomicin.

Fecal Microbiota Transplantation (FMT) has emerged as a highly effective treatment for chronic cases or recurrent infections. It involves transplanting stool from a healthy donor into the patient's gut to restore a balanced microbiome and reduce the likelihood of further recurrences. 

Probiotics (beneficial bacteria) are also sometimes used as adjunct therapy to support gut health, although their efficacy in treating C. diff is still under investigation. Long-term antibiotic therapy may be considered in cases of multiple recurrences, though it risks further disrupting gut flora.

Using The C. diff Diet

Nutritional strategies play a critical role in supporting recovery from C. diff. 

  • During the acute phase of infection, a diet rich in easily digestible, low-fiber foods is often recommended to reduce digestive strain. 
  • Avoid foods high in fiber, dairy products, and spicy or fatty foods, which can exacerbate symptoms like diarrhea and abdominal pain.

Probiotics are particularly important in managing C. diff, as they help replenish the gut's beneficial bacteria. Prebiotics, which are fibers that feed these good bacteria, can also support recovery. Examples include foods like bananas, onions, and garlic. Consult a healthcare provider before starting probiotics or any dietary changes.

Preventing C. diff Recurrence

Preventing the recurrence of C. diff infections requires diligent hygiene practices and proactive measures. 

  • Handwashing with soap and water is critical, especially after using the bathroom or before eating, as C. diff spores are resistant to alcohol-based hand sanitizers. 
  • Sanitizing surfaces with bleach-based cleaners is also essential since C. diff spores can survive on surfaces for long periods.
  • C. diff is contagious, mainly through the fecal-oral route. Both patients and caregivers must follow strict hygiene protocols. Caregivers should wear gloves when handling contaminated items, and patients should be isolated in healthcare settings to prevent the spread of the bacteria.

Proactive measures include closely monitoring symptoms for any signs of recurrence, such as persistent diarrhea or abdominal pain, and seeking prompt medical attention if symptoms return. 

Regular follow-ups with healthcare providers are vital to ensure effective infection management and to discuss any additional preventive strategies, such as the use of probiotics or changes in diet.

By adhering to these practices, patients and caregivers can significantly reduce the risk of C. diff recurrence and its associated complications.

Patient and Caregiver Resources

Managing C. diff can be challenging, but various educational resources are available to help patients and caregivers understand and manage the condition. The Centers for Disease Control and Prevention (CDC) offer comprehensive guides on C. diff symptoms, treatment options, and prevention strategies. These resources help better understand the disease and the latest recommendations.

Support groups and online communities offer invaluable emotional support and practical advice for those suffering from chronic C. diff. platforms like the C. diff Foundation and Peggy Lillis Foundation offer forums where patients and caregivers can share experiences, ask questions, and connect with others facing similar challenges.

Maintaining ongoing communication with healthcare providers is essential in managing C. diff effectively. Regular follow-ups and open dialogue with healthcare professionals also allow for discussing new treatment options and preventive measures, which can significantly improve patient outcomes.

[signup]

Key Takeaways

  • Understanding C. diff: A bacterial infection causing severe gastrointestinal issues, with symptoms like persistent diarrhea, abdominal pain, and fever.
  • Treatment Options: First-line treatments include antibiotics (vancomycin, fidaxomicin). Chronic cases may require fecal microbiota transplantation (FMT) and probiotics.
  • Diet and Recovery: Nutritional strategies support gut health, including low-fiber foods and probiotics. During recovery, avoid high-fiber, dairy, and spicy foods.
  • Preventing Recurrence: Emphasize hygiene practices such as handwashing and sanitizing surfaces. Monitoring symptoms and regular follow-ups with healthcare providers are crucial.
  • Contagious Nature: C. diff is highly infectious, and strict hygiene protocols and isolation in healthcare settings are necessary to prevent its spread.
  • Patient and Caregiver Resources: Utilize educational materials and support groups and maintain ongoing communication with healthcare providers.
  • Seek advice from a medical professional for accurate diagnosis and appropriate treatment of C. diff.
  • Managing chronic C. diff requires proper medical care, vigilant hygiene practices, and continuous support from healthcare providers and resources.

Clostridioides difficile (C. diff) is a serious infection that often occurs in hospitals, especially in patients taking antibiotics. It can cause severe stomach problems and is a major concern in healthcare. Its incidence has doubled in the past two decades to approximately 95 cases per 100,000 in acute care settings.

Chronic C. diff is when the infection keeps coming back and is especially important to address because it can make life very difficult for patients. This article will explain what C. diff is, how it affects people, how it is diagnosed and managed, ways to help prevent it from returning, and tips for managing the infection.  

What is C. diff?

Clostridioides difficile, commonly known as C. diff, is a bacteria that can cause severe inflammation of the colon, known as colitis. It is an anaerobic, spore-forming bacterium that naturally resides in the gut of some healthy people without causing harm. 

However, when the normal balance of bacteria in the gut is disrupted, C. diff can overgrow and produce toxins that may damage the intestinal lining, leading to symptoms like diarrhea, fever, and abdominal pain.

C. diff infections are classified into two categories: acute and chronic.

  • Acute C. diff infections typically present with sudden, severe symptoms and require prompt medical intervention. 
  • Chronic C. diff infections are marked by recurring episodes of the disease, often challenging to manage and leading to long-term health complications.

How Do You Get C. diff?

C. diff is primarily spread through the fecal-oral route. This means the bacteria or its spores can be transmitted when someone ingests contaminated food, water, or surfaces. 

Risk factors for acquiring C. diff include: 

  • Recent antibiotic use
  • Prolonged hospitalization
  • A weakened immune system (e.g., persons with HIV/AIDS, taking immunosuppressants)
  • Advanced age (65 or older)

The antibiotics most often linked to the risk of C.diff infection include:

  • Cephalosporins
  • Clindamycin
  • Fluoroquinolones
  • Penicillin

C. diff infections can be hospital-acquired or community-acquired:

  • Hospital-acquired infections are more common and typically occur when patients are exposed to the bacteria within healthcare settings, where C. diff spores can persist on surfaces for long periods. 
  • Community-acquired infections, although less common, occur outside of healthcare environments.

Is C. diff Contagious?

C. diff is contagious, particularly in healthcare settings where spores can easily spread from person to person or by contaminated surfaces. 

To help prevent the spread of C. diff, take the following precautions: 

  • Practice proper hand hygiene.
  • Use personal protective equipment (PPE).
  • Thoroughly disinfect surfaces with appropriate cleaning agents that may help manage C. diff spores.

Healthcare providers should isolate infected patients to help prevent the bacteria from spreading to others.

What are the Symptoms of C. diff Infection?

C. diff infections range from mild to severe, with symptoms varying in intensity. Common symptoms include:

  • Persistent diarrhea, which may occur multiple times a day, is often accompanied by abdominal pain and cramping.
  • Fever is also a frequent symptom, indicating the body's response to the infection. 
  • Dehydration, nausea, loss of appetite, and weight loss in severe cases.

One of the distinctive signs of C. diff infection is the appearance and odor of the stool. C. diff stool is typically watery, sometimes with a greenish hue, and may contain mucus. It has a distinctive, foul odor, often described as being particularly strong and unpleasant, which can be a key indicator of the infection.

Chronic symptoms may include recurring bouts of diarrhea and abdominal pain, even after initial management. This can result in more severe complications, such as inflammation of the colon (colitis) and, in extreme cases, life-threatening conditions like toxic megacolon or sepsis.

How Do You Diagnose a C. diff Infection?

Diagnosing C. diff usually involves a combination of stool tests and other diagnostic methods. 

  • The most common diagnostic approach is a stool test, which looks for C. diff toxins or the bacteria's DNA. These tests are highly specific and sensitive, helping to confirm the diagnosis.
  • In some cases, a colonoscopy or sigmoidoscopy may be performed to visually examine the colon for signs of inflammation or pseudomembranous colitis, a hallmark of severe C. diff infection. 
  • Imaging tests like CT scans might be used in severe cases to assess complications such as colonic distension (the colon wall distends).

Interpretation of test results guides management decisions. A positive stool test typically confirms the infection, prompting immediate management with antibiotics like vancomycin or fidaxomicin. 

Chronic C. diff and Long-term Implications

Once a person has C. diff, the infection can be challenging to manage, leading to high recurrence rates. Approximately 20-30% of individuals experience a recurrence after their initial infection, and some may become chronic carriers, harboring the bacteria without symptoms. This makes them vulnerable to future infections, especially if their gut microbiome becomes disrupted again.

Long-term problems after C. diff include ongoing GI issues such as persistent diarrhea, abdominal pain, and bloating. The risk of recurrence remains high, particularly in those with weakened immune systems or those who continue to take antibiotics. 

These recurring infections can significantly impact a person's quality of life, leading to frequent medical visits, potential hospitalizations, and chronic discomfort.

C. diff Management and Support

Antibiotics are the primary management approach for C. diff infections. First-line treatments typically include vancomycin or fidaxomicin for at least 10 days. Metronidazole may be used in mild cases but is less preferred due to its lower efficacy than vancomycin and fidaxomicin.

Fecal Microbiota Transplantation (FMT) has emerged as a highly effective approach for chronic cases or recurrent infections. It involves transplanting stool from a healthy donor into the patient's gut to help restore a balanced microbiome and reduce the likelihood of further recurrences. 

Probiotics (beneficial bacteria) are also sometimes used as adjunct therapy to support gut health, although their efficacy in managing C. diff is still under investigation. Long-term antibiotic therapy may be considered in cases of multiple recurrences, though it risks further disrupting gut flora.

Using The C. diff Diet

Nutritional strategies play a critical role in supporting recovery from C. diff. 

  • During the acute phase of infection, a diet rich in easily digestible, low-fiber foods is often recommended to reduce digestive strain. 
  • Avoid foods high in fiber, dairy products, and spicy or fatty foods, which can exacerbate symptoms like diarrhea and abdominal pain.

Probiotics are particularly important in managing C. diff, as they help replenish the gut's beneficial bacteria. Prebiotics, which are fibers that feed these good bacteria, can also support recovery. Examples include foods like bananas, onions, and garlic. Consult a healthcare provider before starting probiotics or any dietary changes.

Preventing C. diff Recurrence

Preventing the recurrence of C. diff infections requires diligent hygiene practices and proactive measures. 

  • Handwashing with soap and water is critical, especially after using the bathroom or before eating, as C. diff spores are resistant to alcohol-based hand sanitizers. 
  • Sanitizing surfaces with bleach-based cleaners is also essential since C. diff spores can survive on surfaces for long periods.
  • C. diff is contagious, mainly through the fecal-oral route. Both patients and caregivers must follow strict hygiene protocols. Caregivers should wear gloves when handling contaminated items, and patients should be isolated in healthcare settings to help prevent the spread of the bacteria.

Proactive measures include closely monitoring symptoms for any signs of recurrence, such as persistent diarrhea or abdominal pain, and seeking prompt medical attention if symptoms return. 

Regular follow-ups with healthcare providers are vital to ensure effective infection management and to discuss any additional preventive strategies, such as the use of probiotics or changes in diet.

By adhering to these practices, patients and caregivers can significantly reduce the risk of C. diff recurrence and its associated complications.

Patient and Caregiver Resources

Managing C. diff can be challenging, but various educational resources are available to help patients and caregivers understand and manage the condition. The Centers for Disease Control and Prevention (CDC) offer comprehensive guides on C. diff symptoms, management options, and prevention strategies. These resources help better understand the disease and the latest recommendations.

Support groups and online communities offer invaluable emotional support and practical advice for those suffering from chronic C. diff. Platforms like the C. diff Foundation and Peggy Lillis Foundation offer forums where patients and caregivers can share experiences, ask questions, and connect with others facing similar challenges.

Maintaining ongoing communication with healthcare providers is essential in managing C. diff effectively. Regular follow-ups and open dialogue with healthcare professionals also allow for discussing new management options and preventive measures, which can significantly improve patient outcomes.

[signup]

Key Takeaways

  • Understanding C. diff: A bacterial infection causing severe gastrointestinal issues, with symptoms like persistent diarrhea, abdominal pain, and fever.
  • Management Options: First-line treatments include antibiotics (vancomycin, fidaxomicin). Chronic cases may require fecal microbiota transplantation (FMT) and probiotics.
  • Diet and Recovery: Nutritional strategies support gut health, including low-fiber foods and probiotics. During recovery, avoid high-fiber, dairy, and spicy foods.
  • Preventing Recurrence: Emphasize hygiene practices such as handwashing and sanitizing surfaces. Monitoring symptoms and regular follow-ups with healthcare providers are crucial.
  • Contagious Nature: C. diff is highly infectious, and strict hygiene protocols and isolation in healthcare settings are necessary to help prevent its spread.
  • Patient and Caregiver Resources: Utilize educational materials and support groups and maintain ongoing communication with healthcare providers.
  • Seek advice from a medical professional for accurate diagnosis and appropriate management of C. diff.
  • Managing chronic C. diff requires proper medical care, vigilant hygiene practices, and continuous support from healthcare providers and resources.
The information provided is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any dietary supplement or making any changes to your diet or exercise routine.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Anderson, S. (2022, September 14). This is What Happens to Your Body When You are Dehydrated. Rupa Health. https://www.rupahealth.com/post/this-is-what-happens-to-your-body-when-you-are-dehydrated

Bakken, J. S., Borody, T., Brandt, L. J., Brill, J. V., Demarco, D. C., Franzos, M. A., Kelly, C., Khoruts, A., Louie, T., Martinelli, L. P., Moore, T. A., Russell, G., & Surawicz, C. (2011). Treating Clostridium difficile Infection With Fecal Microbiota Transplantation. Clinical Gastroenterology and Hepatology, 9(12), 1044–1049. https://doi.org/10.1016/j.cgh.2011.08.014

Bertagna, B. (2024, February 15). Exploring the Link Between The Gut Microbiome and Clostridium Difficile in Diabetes. Rupa Health. https://www.rupahealth.com/post/exploring-the-link-between-microbiome-and-clostridium-difficile-in-diabetes

Bertagna, B. (2024b, February 21). The Gut Microbiome: A Key Player in Chronic Disease Management. Rupa Health. https://www.rupahealth.com/post/the-gut-microbiome-a-key-player-in-chronic-disease-management

Bhattacharyya, M., Debnath, A. K., & Todi, S. K. (2020). Clostridium difficile and Antibiotic-associated Diarrhea. Indian Journal of Critical Care Medicine, 24(S4), S162–S167. https://doi.org/10.5005/jp-journals-10071-23619

C Diff Foundation. (2019). C Diff Foundation. HCP Live. https://www.hcplive.com/sap-partner/cdifffoundation

Carroll, K. C., & Mizusawa, M. (2020). Laboratory Tests for the Diagnosis of Clostridium difficile. Clinics in Colon and Rectal Surgery, 33(02), 073–081. https://doi.org/10.1055/s-0039-3400476

CDC. (2024a). About HIV. HIV. https://www.cdc.gov/hiv/about/index.html

CDC. (2024a, April 23). Preventing C. diff. C. Diff (Clostridioides Difficile). https://www.cdc.gov/c-diff/prevention/index.html

CDC. (2024b, May 6). About C. diff. C. Diff (Clostridioides Difficile). https://www.cdc.gov/c-diff/about/index.html

CDC. (2024c, May 14). C. diff: Facts for Clinicians. C. Diff (Clostridioides Difficile). https://www.cdc.gov/c-diff/hcp/clinical-overview/index.html

Cleveland Clinic. (2023, May 10). C. diff (Clostridioides difficile) Infection: What You Need To Know. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/15548-c-diff-infection

Cleveland Clinic. (2019). Colonoscopy. Cleveland Clinic. https://my.clevelandclinic.org/health/diagnostics/4949-colonoscopy

Cloyd, J. (2023a, April 19). What's the Difference Between Prebiotics vs. Probiotics vs. Postbiotics? Rupa Health. https://www.rupahealth.com/post/whats-the-difference-between-prebiotics-vs-probiotics-vs-postbiotics

Cloyd, J. (2023b, April 20). Antibiotics 101: What You Need To Know. Rupa Health. https://www.rupahealth.com/post/antibiotics-101-what-you-need-to-know

Cloyd, J. (2023b, July 28). A functional medicine diarrhea protocol: Comprehensive lab testing, therapeutic diet, and supplements. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-diarrhea-protocol-comprehensive-lab-testing-therapeutic-diet-and-supplements

FDA. (2024). FDA Approves First Orally Administered Fecal Microbiota Product for the Prevention of Recurrence of Clostridioides difficile Infection. U.S. Food and Drug Administration. https://www.fda.gov/news-events/press-announcements/fda-approves-first-orally-administered-fecal-microbiota-product-prevention-recurrence-clostridioides

Johns Hopkins Medicine. (n.d.). Toxic Megacolon. Www.hopkinsmedicine.org. https://www.hopkinsmedicine.org/health/conditions-and-diseases/toxic-megacolon

Kim, G. (2013). Cleaning Recommendations for Prevention of Infectious Agent Transmission: Clostridium difficile Toolkit for Long-term Care Facilities - Minnesota Dept. of Health. State.mn.us. https://www.health.state.mn.us/diseases/cdiff/hcp/ltctoolkit/cleaning.html

Kim, G., & Zhu, N. A. (2017). Community-acquired Clostridium difficile infection. Canadian Family Physician, 63(2), 131–132. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395385/

Lessa, F. C., Mu, Y., Bamberg, W. M., Beldavs, Z. G., Dumyati, G. K., Dunn, J. R., Farley, M. M., Holzbauer, S. M., Meek, J. I., Phipps, E. C., Wilson, L. E., Winston, L. G., Cohen, J. A., Limbago, B. M., Fridkin, S. K., Gerding, D. N., & McDonald, L. C. (2015). Burden of Clostridium difficile Infection in the United States. New England Journal of Medicine, 372(9), 825–834. https://doi.org/10.1056/nejmoa1408913

Maroo, S., & Lamont, J. T. (2006). Recurrent Clostridium Difficile. Gastroenterology, 130(4), 1311–1316. https://doi.org/10.1053/j.gastro.2006.02.044

Mayo Clinic. (2019). Pseudomembranous colitis - Symptoms and causes. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/pseudomembranous-colitis/symptoms-causes/syc-20351434

Mayo Clinic. (2023a). Sepsis - symptoms and causes. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/sepsis/symptoms-causes/syc-20351214

Mayo Clinic. (2023, September 1). C. difficile infection . Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/c-difficile/symptoms-causes/syc-20351691

Mayo Clinic. (2023c, September 1). C. difficile infection - Diagnosis and treatment - Mayo Clinic. Mayoclinic.org. https://www.mayoclinic.org/diseases-conditions/c-difficile/diagnosis-treatment/drc-20351697

McFarland, L. V., Surawicz, C. M., Rubin, M., Fekety, R., Elmer, G. W., & Greenberg, R. N. (1999). Recurrent Clostridium Difficile Disease: Epidemiology and Clinical Characteristics. Infection Control & Hospital Epidemiology, 20(01), 43–50. https://doi.org/10.1086/501553

Na, X., & Kelly, C. (2011). Probiotics in Clostridium difficile Infection. Journal of Clinical Gastroenterology, 45, S154–S158. https://doi.org/10.1097/mcg.0b013e31822ec787

Oncology Nutrition. (n.d.). Diet and C.Difficile. Www.oncologynutrition.org. https://www.oncologynutrition.org/erfc/eating-well-when-unwell/surgery/diet-and-c-difficile

Peggy Lillis Foundation. (n.d.). see C. diff. Cdiff.org. https://cdiff.org/

Penn Medicine. (2022). Colitis. Pennmedicine.org. https://www.pennmedicine.org/for-patients-and-visitors/patient-information/conditions-treated-a-to-z/colitis

Perera, H. (2024, April 11). The Ultimate Fiber Foods List: Boost Your Health with High-Fiber Choices. Rupa Health. https://www.rupahealth.com/post/ultimate-fiber-foods-list

Ragusa, R., Giorgianni, G., Lupo, L., Sciacca, A., Rametta, S., La Verde, M., Mulè, S., & Marranzano, M. (2018). Healthcare-associated Clostridium difficile infection: role of correct hand hygiene in cross-infection control. Journal of Preventive Medicine and Hygiene, 59(2), E145–E152. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069405/

Rupa Health. (2020). Clostridium difficile Toxin A | Rupa Health. Rupa Health. https://www.rupahealth.com/biomarkers/clostridium-difficile-toxin-a-15451

Salamon, M. (2023, November 1). Long-lasting C. diff infections: A threat to the gut. Harvard Health. https://www.health.harvard.edu/blog/long-lasting-c-diff-infections-a-threat-to-the-gut-202311012987

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on GI Health
Subscribe to the Magazine for free
Subscribe for free to keep reading! If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey Practitioners! Ready to become a world class gut health expert? Join Jeannie Gorman, MS, CCN, for a Free Live Class that dives into how popular diets impact the gut microbiome, the clinical dietary needs of your gut, biomarkers to test to analyze gut health, and gain a clear understanding of the Doctor’s Data GI360™ profile. Register here.